Cite
HARVARD Citation
Peters, B. et al. (2018). Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study. Nephrology. 23 (4), pp. 366-370. [Online].